- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Interpace Biosciences Inc (IDXG)
Interpace Biosciences Inc stock price live, this page displays OTC IDXG stock exchange data. View the IDXG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Interpace Biosciences Inc real time stock price chart below.
What Is the Interpace Biosciences Inc Stock Price Today?
The Interpace Biosciences Inc stock price today is 0.8600.
What Is the Stock Symbol for Interpace Biosciences Inc?
The stock symbol for Interpace Biosciences Inc is ""IDXG.""
What Stock Exchange Does Interpace Biosciences Inc Trade On?
Interpace Biosciences Inc is listed and trades on the OTC Markets stock exchange.
Is Interpace Biosciences Inc a Good Stock to Buy?
Determining whether Interpace Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IDXG quote. (ISIN: US46062X3035)
What Is the Interpace Biosciences Inc Stock Price Today?
The Interpace Biosciences Inc stock price today is 0.8600.
What Is the Stock Symbol for Interpace Biosciences Inc?
The stock symbol for Interpace Biosciences Inc is ""IDXG.""
What Stock Exchange Does Interpace Biosciences Inc Trade On?
Interpace Biosciences Inc is listed and trades on the OTC Markets stock exchange.
Is Interpace Biosciences Inc a Good Stock to Buy?
Determining whether Interpace Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IDXG quote. (ISIN: US46062X3035)
OTC Markets
Currency in USD
0.8600
-0.0355(-3.96%)
Closed·
Fair Value
An estimate of a Interpace Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8600
0.8700
52 wk Range
0.4433
3.5400
IDXG Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 6 days
More Info
Fair Value
An estimate of a Interpace Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.86000.8700
52 wk Range
0.44333.5400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IDXG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Interpace Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Interpace Biosciences Misses Q2 EPS by 41c
- Investing.com
- Interpace Biosciences Misses Q2 EPS by 41c
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Interpace Biosciences Inc Company Profile
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis of pancreaticobiliary cancers using its proprietary PathFinderTG platform; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using a proprietary microRNA gene expression classifier; and RespriDx, a genomic test that enables physicians to differentiate metastatic or recurrent lung cancer. It primarily serves physicians, cancer centers, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Compare IDXG to Peers and Sector
Metrics to compare | IDXG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIDXGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.5x | −0.2x | −0.5x | |
PEG Ratio | −0.01 | 0.01 | 0.00 | |
Price/Book | −6.6x | 1.6x | 2.6x | |
Price / LTM Sales | 0.1x | 1.0x | 3.3x | |
Upside (Analyst Target) | - | 48.8% | 42.4% | |
Fair Value Upside | Unlock | 27.6% | 7.2% | Unlock |
Earnings
Latest Release
May 19, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
11.52M / --
FAQ
What Stock Exchange Does Interpace Biosciences Trade On?
Interpace Biosciences is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Interpace Biosciences?
The stock symbol for Interpace Biosciences is "IDXG."
What Is the Interpace Biosciences Market Cap?
As of today, Interpace Biosciences market cap is 3.80M.
What Is Interpace Biosciences's Earnings Per Share (TTM)?
The Interpace Biosciences EPS (TTM) is 1.69.
When Is the Next Interpace Biosciences Earnings Date?
Interpace Biosciences will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is IDXG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Interpace Biosciences Stock Split?
Interpace Biosciences has split 2 times.
How Many Employees Does Interpace Biosciences Have?
Interpace Biosciences has 111 employees.
What is the current trading status of Interpace Biosciences (IDXG)?
As of 31 Jul 2025, Interpace Biosciences (IDXG) is trading at a price of 0.86, with a previous close of 0.90. The stock has fluctuated within a day range of 0.86 to 0.87, while its 52-week range spans from 0.44 to 3.54.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.